Head-to-head · WeighScore
Strut Health vs Tablet Health
The verdict
Strut Health takes it — 79.4/100 to 50/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Strut Health | Tablet Health |
|---|---|---|
| WeighScore | 79.4/100 | 50/100 |
| Grade | C+ | C |
| Scorecard rank | #29 | #535 |
| Semaglutide | From $99/mo sublingual, $149/mo injectable | Not disclosed |
| Tirzepatide | From $199/mo either route | Not disclosed |
| Coverage | 49 states (not Arkansas) | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #29 · C+
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
Where it loses points
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring program
- Compounded only, with no brand-name lane
- Not available in Arkansas
Graded #535 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.